Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations
- 1 July 1994
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 97 (1) , 19-25
- https://doi.org/10.1111/j.1365-2249.1994.tb06573.x
Abstract
SUMMARY: This study was addressed to explore the reactivity of natural anti-idiotypes from commercial lots of immunoglobulins to several idiotypes (Ids), usually expressed by anti-DNA molecules in lupus nephritis. Eleven intravenous immunoglobulin (IVIG) preparations and nine (three polyvalent and six hyper-immune) intramuscular IgG were Investigated for specific content of anti-DNA, anti-F(ab′)2 and antibodies reacting with several anti-DNA IgG Ids. Two samples (nos 6 and 11) showed high reactivity with allogeneic F(ab′)2 and with F(ab′)2 of myeloma proteins bearing the anti-DNA Id 31+ and the 8.12+. Since both 31 and 8.12 Id markers are known to characterize pathogenic anti-DNA IgG in systemic lupus erythematosus (SLE), anti-Id antibodies to these markers were obtained by absorbing the IVIG samples nos 6 and 11 to Sepharose columns coupled with pooled (ab′)2 fragments of 31+-F4+-8.12+-myeloma proteins. Inhibition experiments showed that anti-8.12 Id-eluted IgG induced a selective suppression of the DNA-reactive antibodies derived from patients with active lupus nephritis to their substrate, suggesting the involvement of 8.12+ molecules in the SLE glomerular damage. Since 8.12+ anti-DNA are nephritogenic antibodies, the occurrence of anti-8.12+ Id in commercial IVIG may be of potential therapeutic relevance in modulating the pathogenic SLE Id network. Previous variable results of IVIG treatment in SLE, such as resolution of proteinuria or worsening nephritis, could be related to variable enrichment of different lots of IVIG in suppressive anti-pathogenic Id antibodies.Keywords
This publication has 24 references indexed in Scilit:
- Autoimmune diseases — at the molecular levelImmunology Today, 1993
- Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic networkClinical Immunology and Immunopathology, 1992
- Parallelism of serum anti-F(ab′)2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1991
- Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivityImmunology Today, 1990
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Intravenous γ-globulin therapy in systemic lupus erythematosus and immune complex diseaseClinical Immunology and Immunopathology, 1989
- In vitro inhibition of anti-DNA producing cells from systemic lupus erythematosus patients by autologous anti-F(ab′)2 antibodiesClinical Immunology and Immunopathology, 1987
- Studies of anti‐f(ab')2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosusArthritis & Rheumatism, 1984
- Heparan Sulfate–Rich Anionic Sites in the Human Glomerular Basement MembraneNew England Journal of Medicine, 1983